OpenEvidence 與 Johns Hopkins Medicine 合作推進 AI 醫學教育及臨牀照護

OpenEvidence and Johns Hopkins Medicine on October 13, 2026 announced a strategic collaboration to reshape medical education and clinical care for the era of artificial intelligence. The partnership is built on two foundational pillars: readying the next generation of clinicians for the environment in which they will practice, and grounding every patient’s care in the most current evidence-based clinical guidelines.

Datelined Miami, FL and Baltimore, MD, the announcement frames the effort’s ultimate aim as using AI to serve better outcomes for patients. The two organizations said the collaboration starts from a shared conviction that the transformation AI is bringing to medicine requires deliberately redesigning both how clinicians are educated and how care is practiced. As AI grows able to retrieve and condense the world’s medical knowledge within seconds, they said, the clinician’s role moves toward the work that cannot be automated — reasoning from first principles, exercising clinical and contextual judgment, and the human work of caring for patients.

Medical Education in an AI-Native Environment

More than a century ago, Johns Hopkins created the model of medical education now used in the United States, according to the announcement, which describes OpenEvidence as the most widely adopted medical AI in the country and says it has changed how physicians access and use medical knowledge.

Together, the organizations said they will design a medical education model that reinforces foundational principles: a deep understanding of pathophysiology, evidence-based medicine, clinical reasoning from first principles, and the diagnostic and interpersonal skills central to capable, compassionate care. Alongside that work, they plan to create novel adaptive AI systems that prepare physicians to lead and to keep learning in an AI-native environment. The organizations said their goal is to define what rigorous, patient-centered medical education looks like in the AI era, much as Johns Hopkins set the standard for 20th-century medical training.

Sanjay Desai, MD, MACP, Vice Dean for Education at Johns Hopkins Medicine, said: “Johns Hopkins designed modern medical education around a simple idea: that physicians learn medicine at the bedside, grounded in science and reasoning. The arrival of AI, in many ways, invites us back to the bedside with new tools and capabilities we have yet to fully imagine. Working with OpenEvidence enables us to design and inspire, very deliberately, the model of education and the practice of medicine for this new era.”

Travis Zack, MD, PhD, Chief Medical Officer of OpenEvidence, said the issue before medicine is who will define AI’s impact on the physician’s role, and on what principles, rather than whether AI will alter that role at all. He said medicine’s future should be built deliberately rather than merely reacted to, with patients at the center, and he described Johns Hopkins as the birthplace of modern medical education.

Human-First AI Systems for Care Delivery

OpenEvidence and Johns Hopkins Medicine said they will also develop human-first AI systems designed to improve care delivery. The planned systems are intended to bring together the best available evidence, the patient’s own medical history, and best practices established at Johns Hopkins Medicine, helping clinicians reason through that information more quickly, place it in context, and reach the best decision for their patient.

Sara Murray, MD, MAS, Chief Medical Informatics & AI Officer at Johns Hopkins Medicine, said: “Johns Hopkins clinicians always strive to deliver the best care in the world. This collaboration with OpenEvidence is an opportunity to build on that — giving them tools that make every encounter more informed, more precise, and more attuned to the individual patient in front of them.”

Recent OpenEvidence Partnerships

The Johns Hopkins announcement follows several OpenEvidence collaborations with health systems and academic medical centers announced in the preceding weeks.

On September 15, 2026, OpenEvidence and Penn Medicine announced a global partnership under which AI-powered clinical decision support will reach more than 10,000 Penn Medicine clinicians across a seven-hospital U.S. health system. The agreement also extends that decision support into low- and middle-income countries through the Botswana-UPenn Partnership.

On September 16, 2026, OpenEvidence and Memorial Sloan Kettering Cancer Center announced a partnership to integrate OpenEvidence within MSK’s Epic electronic health record workflow and to bring OncoKB, MSK’s precision oncology knowledge base, directly into OpenEvidence for broader use by providers outside MSK.

On October 1, 2026, AdventHealth and OpenEvidence announced that OpenEvidence would be made available to physicians, nurses, pharmacists, care managers, therapists and other clinical roles across AdventHealth, integrated into their existing workflows within the electronic health record system.